Cargando…
Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy
Autor principal: | Thaweerat, Wajana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800838/ https://www.ncbi.nlm.nih.gov/pubmed/35094260 http://dx.doi.org/10.1007/s12149-021-01712-6 |
Ejemplares similares
-
Comparison of post-COVID-19 vaccination hypermetabolic lymphadenopathy on (18)F-fluorodeoxyglucose PET/CT between virus-vector vaccine and mRNA vaccine
por: Chiang, Meng-Ting, et al.
Publicado: (2023) -
Hypermetabolic Ipsilateral Supraclavicular and Axillary Lymphadenopathy: Optimal Time Point for Performing an (18)F-FDG PET/CT after COVID-19 Vaccination
por: Antwi, Kwadwo, et al.
Publicado: (2022) -
Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [(18)F]FDG PET-CT and relevance to study interpretation
por: Cohen, Dan, et al.
Publicado: (2021) -
Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022) -
Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
por: Felices-Farias, Jose Manuel, et al.
Publicado: (2022)